Generic Drug Firms Want CMS To Change Proposed Definition Of “Original NDA”
Executive Summary
How CMS defines an “original NDA” for the purpose of rebate payments in its proposed Medicaid rule could mean some drugs currently charged at the generic drug rebate rate will soon be charged the higher brand drug rate.